Fate Therapeutics (FATE) Other Accumulated Expenses (2013 - 2026)
Fate Therapeutics (FATE) reported Other Accumulated Expenses of $3.28 million for Q2 2026, down 32.6% from $4.87 million a year earlier and down 17.1% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics posted Other Accumulated Expenses of $4.41 million, down 30.6% from FY2024.
- Other Accumulated Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $6.36 million in FY2024 (-21.7%), $8.12 million in FY2023 (-57.7%), $19.18 million in FY2022 (+63.7%) and $11.71 million in FY2021 (+112.7%).
- The Q2 2026 figure ranks as the lowest quarterly Other Accumulated Expenses since Q2 2020.
- Year over year, Other Accumulated Expenses has now declined in each of the last seven quarters, with an average decline of 33.9% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2021 (growth of 183.2%); the low point was Q1 2025 (a decline of 63.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.96 million (Q1 2026), $4.41 million (Q4 2025) and $3.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.71 Mn |
| Jun 30, 2026 | 3.28 Mn |
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 4.87 Mn |
| Mar 31, 2025 | 6.77 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 8.01 Mn |
| Mar 31, 2024 | 18.65 Mn |
| Dec 31, 2023 | 8.12 Mn |
| Sep 30, 2023 | 8.63 Mn |
| Jun 30, 2023 | 8.11 Mn |
| Mar 31, 2023 | 10.23 Mn |
| Dec 31, 2022 | 19.18 Mn |
| Sep 30, 2022 | 18.90 Mn |
| Jun 30, 2022 | 12.29 Mn |
| Mar 31, 2022 | 13.03 Mn |
| Dec 31, 2021 | 11.71 Mn |
API Access
Fate Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();